Skip to main content
CURI
NASDAQ Trade & Services

Shareholders Reject Proposal to Expand Equity Incentive Plan

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$2.63
Mkt Cap
$152.962M
52W Low
$2.3
52W High
$7.15
Market data snapshot near publication time

Summary

CuriosityStream shareholders rejected a proposal to increase the company's equity incentive plan by 1,000,000 shares, preventing potential future dilution.


Key Events

  • Incentive Plan Expansion Rejected

    Stockholders did not approve an amendment to increase the number of shares authorized for issuance under the 2020 Omnibus Incentive Plan by 1,000,000 shares. This prevents potential future dilution from equity awards.

  • Directors Re-elected

    Three Class III directors (Matthew Blank, Jonathan Huberman, and Mike Nikzad) were elected to serve three-year terms expiring in 2029.

  • Auditor Ratified & Executive Compensation Approved

    The appointment of Grant Thornton LLP as the independent auditor for 2026 was ratified, and executive compensation was approved on an advisory basis. Stockholders also recommended a one-year frequency for future advisory votes on executive compensation.


Analysis

Shareholders voted against increasing the share pool for the 2020 Omnibus Incentive Plan by 1,000,000 shares. This decision prevents potential future dilution for existing shareholders, as these shares would have been available for equity awards. The rejection signals shareholder pushback against further dilution.

At the time of this filing, CURI was trading at $2.63 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $153M. The 52-week trading range was $2.30 to $7.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CURI - Latest Insights

CURI
May 29, 2026, 4:02 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.86
Real-time Price: $2.56 info
Change: -$0.300 (-10%) info
Market Cap: $150.591M info
CURI
May 21, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.63
Real-time Price: $2.56 info
Change: -$0.070 (-3%) info
Market Cap: $150.591M info
CURI
May 14, 2026, 5:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.85
Real-time Price: $2.56 info
Change: -$0.290 (-10%) info
Market Cap: $150.591M info
CURI
May 14, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.76
Real-time Price: $2.56 info
Change: -$0.1999 (-7%) info
Market Cap: $150.591M info
CURI
Apr 10, 2026, 9:06 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $2.56 info
Change: -$0.660 (-20%) info
Market Cap: $150.591M info
CURI
Mar 12, 2026, 5:00 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.21
Real-time Price: $2.56 info
Change: -$0.650 (-20%) info
Market Cap: $150.591M info
CURI
Mar 11, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.20
Real-time Price: $2.56 info
Change: -$0.640 (-20%) info
Market Cap: $150.591M info
CURI
Mar 11, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.38
Real-time Price: $2.56 info
Change: -$0.820 (-24%) info
Market Cap: $150.591M info
CURI
Feb 05, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.17
Real-time Price: $2.56 info
Change: -$0.610 (-19%) info
Market Cap: $150.591M info
CURI
Feb 04, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.43
Real-time Price: $2.56 info
Change: -$0.870 (-25%) info
Market Cap: $150.591M info